<DOC>
	<DOCNO>NCT00539422</DOCNO>
	<brief_summary>The aim study investigate potential role CYP2D6*4 polymorphism breast cancer furthermore assess role oxidative stress , antioxidant capacity ferretin pathogenesis breast cancer different CYP2D6*4 genotype</brief_summary>
	<brief_title>Role Cytochrome P450 2D6 ( CYP2D6 ) *4 Polymorphism , Malignant Breast Diseases</brief_title>
	<detailed_description>Breast cancer common malignancy among woman second high cause cancer death . Nevertheless breast cancer sporadic family history disease , Enhanced CYP2D6 activity related malignancy bladder , liver , pharynx , stomach , especially , cigarette-smoking-induced lung cancer . Data support increase formation reactive oxygen specie ( ROS ) may play important role carcinogenesis Numerous vitro experiment show ROS damage DNA , induce premutagenic modification nucleotide promote oxidation protein lipid per oxidation The aim study investigate potential role CYP2D6*4 polymorphism breast cancer furthermore assess role oxidative stress , antioxidant capacity ferretin pathogenesis breast cancer different CYP2D6*4 genotypes.patients method : This study include 31 woman admit general surgery department , Mansoura University Hospital . group I consist 15 woman benign breast lesion , group II compose 16 woman cancer breast 13 healthy woman match age clinically free take control group . DNA extraction genotyping cytochrome P450-2D6*4 gene use conventional PCR follow restriction enzyme ( Mva1 ) digestion . Separated plasma use measurement plasma malondialdehyde ( MDA ) concentration , total plasma antioxidant capacity plasma ferretin level.Results homozygous genotype 2D6*4 represent 56.25 % ( 9/16 ) breast cancer group lower wild type ( 31.25 % -5/16 ) , represent 33.3 % ( 5/15 ) begnine breast lesion group 15.3 ( 2/13 ) control group . Where wild type represent majority case ( 61.15 % -8/13 ) control group 46.6 % -7/15 ) begnine breast lesion group . statistically significant increase plasma ferretin MDA mean level breast cancer group begnine breast lesion control group .Also , increase plasma total antioxidant activity breast cancer group control group nonstatistical difference breast cancer benign breast lesion group . Conclusion CYP2D6*4 genotype polymorphism interact plasma malondialdehyde ( MDA ) oxidative stress plasma ferretin level may role pathogenesis breast cancer</detailed_description>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>This study include 31 woman admit general surgery department , Mansoura University Hospital . group I consist 15 woman benign breast lesion , group II compose 16 woman cancer breast 13 healthy woman match age clinically free take control group .</criteria>
	<gender>Female</gender>
	<minimum_age>33 Years</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>cytochrome 450</keyword>
	<keyword>CYP2D6*4</keyword>
	<keyword>Ferritin</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>cancer</keyword>
	<keyword>cancer breast</keyword>
</DOC>